Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06244368
What this trial is testing

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

Who this might be right for
Peripheral T Cell LymphomaDiffuse Large B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 115
Testing effectiveness (Phase 2)UnknownNCT05771883
What this trial is testing

A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 102
Large-scale testing (Phase 3)Looking for participantsNCT06091254
What this trial is testing

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Regeneron Pharmaceuticals 822
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07206264
What this trial is testing

Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT Assessment

Who this might be right for
Mantle Cell Lymphoma
Tianjin Medical University Cancer Institute and Hospital 45
Early research (Phase 1)Study completedNCT00742144
What this trial is testing

Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular
GlaxoSmithKline 6
Post-approval studies (Phase 4)Looking for participantsNCT07355699
What this trial is testing

Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma(MZL)
Beijing Tongren Hospital 88
Early research (Phase 1)Study completedNCT00556699
What this trial is testing

SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Genentech, Inc. 22
Post-approval studies (Phase 4)Looking for participantsNCT07609719
What this trial is testing

Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

Who this might be right for
Multiple Sclerosis
Genentech, Inc. 100
Large-scale testing (Phase 3)UnknownNCT01678430
What this trial is testing

A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment

Who this might be right for
Chronic Lymphocytic Leukaemia
University of Liverpool 670
Testing effectiveness (Phase 2)UnknownNCT01811368
What this trial is testing

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Refractory Non Hodgkin LymphomaRelapsed Non Hodgkin Lymphoma
Joseph Tuscano 20
Not applicableStudy completedNCT04918940
What this trial is testing

Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Follicular LymphomaMantle Cell Lymphoma
Centre Henri Becquerel 20
Large-scale testing (Phase 3)Study completedNCT00278421
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 592
Testing effectiveness (Phase 2)UnknownNCT02965157
What this trial is testing

Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma

Who this might be right for
Lymphoma, B-Cell
Beijing Biohealthcare Biotechnology Co.,Ltd 15
Testing effectiveness (Phase 2)UnknownNCT02456207
What this trial is testing

A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Non Hodgkin's Lymphoma
Sinocelltech Ltd. 80
Not applicableNot Yet RecruitingNCT07345741
What this trial is testing

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
R/R B-NHLRelapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL)
Donghua Zhang 28
Testing effectiveness (Phase 2)WithdrawnNCT00003663
What this trial is testing

Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)Study completedNCT00220285
What this trial is testing

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaLymphoma, B-CellLymphoma, Low-Grade
Bayer 45
Testing effectiveness (Phase 2)Study completedNCT00071955
What this trial is testing

Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Genitope Corporation
Testing effectiveness (Phase 2)UnknownNCT04553393
What this trial is testing

Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden

Who this might be right for
Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
Chinese PLA General Hospital 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04429438
What this trial is testing

Multi-CAR-T Cells Targeting B Cell Lymphomas

Who this might be right for
B Cell Lymphoma (BCL)
Shenzhen Geno-Immune Medical Institute 11
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation